Ligand Pharmaceuticals (LGND) Inventory (2011 - 2026)

Ligand Pharmaceuticals has disclosed Inventory across 16 years of filings, most recently posting $13.3 million for Q1 2026.

• Inventory for Q1 2026 came in at $13.3 million, down 9.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.3 million (down 9.22% YoY), and the FY2025 annual result was $9.1 million, down 35.34% from the prior year.
• Inventory came in at $13.3 million for Q1 2026 at Ligand Pharmaceuticals, up from $9.1 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $26.9 million in Q2 2023 to a low of $9.1 million in Q4 2025.
• The 5-year median for Inventory is $16.7 million (2024), against an average of $18.3 million.
• Across the five-year window, Inventory plunged 51.35% in 2022 and surged 80.3% in 2023, its largest moves.
• Ligand Pharmaceuticals' Inventory stood at $13.3 million in 2022, then soared by 80.3% to $24.0 million in 2023, then slumped by 41.12% to $14.1 million in 2024, then sank by 35.34% to $9.1 million in 2025, then surged by 45.36% to $13.3 million in 2026.
• The last three Inventory figures came in at $13.3 million (Q1 2026), $9.1 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.